Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NSE - Delayed Quote INR

Krebs Biochemicals & Industries Limited (KREBSBIO.NS)

78.41
-3.42
(-4.18%)
At close: 3:29:13 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Jitendra Rameshchandra Shah MD, CEO & Director 20k -- 1968
Mr. Ritesh Jain Chief Financial Officer -- -- --
Mr. Rakesh R. Kalbate Company Secretary & Compliance Officer -- -- --

Krebs Biochemicals & Industries Limited

Kothapalli Village
Kasimkota Mandal Anakapalli
Visakhapatnam, 531031
India
91 91 2114 4984 https://krebsbiochem.com
Sector: 
Healthcare
Full Time Employees: 
191

Description

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is based in Visakhapatnam, India.

Corporate Governance

Krebs Biochemicals & Industries Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 19, 2025 at 10:59 AM UTC - May 23, 2025 at 12:00 PM UTC

Krebs Biochemicals & Industries Limited Earnings Date

Recent Events

September 14, 2005 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers